Tumor Ablation Market is Determined to Cross US$ 149.00 Billion in Europe By 2024

New York, May 25, 2018: The scope of the report includes a detailed study of Europe and regional markets on Europe Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the Europe market. Key players profiled in the report include Angiodynamics, Mermaid Medical, Medtronic Plc., HealthTronics, Neuwave Medical, Inc. Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Boston Scientific Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Europe Tumor Ablation Market is expected to exceed more than US$ 149.31 Billion by 2022 at a CAGR of 11.6% in the given forecast period.

You Can Browse Full Report @: https://www.marketresearchengine.com/europe-tumor-ablation-market

The major driving factors of Europe Tumor Ablation Market are as follows:

  • Growth in demand for minimally invasive cancer procedures
  • Increase prevalence of cancer
  • New expansion technological advancements
  • Expanding number of hospitals, surgical and ablation centers
  • Increasing awareness about tumor ablation methods over traditional treatments and surgical methods

The restraining factors of Europe Tumor Ablation Market are as follows:

  • Tough regulatory guideline
  • High cost and limited knowledge
  • Ongoing healthcare reforms

The Europe Tumor Ablation Market is segmented on the lines of its technology, treatment, application and regional. Based on technology segmentation it covers radiofrequency ablation, microwave ablation, cryoblation, other technology. Based on treatment segmentation it covers surgical ablation, laparoscopic ablation, percutaneous ablation. Based on application segmentation it covers liver cancer, lung cancer, kidney cancer, bone metastasis, other applications. The Europe Tumor Ablation Market on geographic segmentation covers various regions such as Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe.

This report provides:

1) An overview of the Europe market for Europe Tumor Ablation Market and related technologies.
2) Analyses of Europe market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Europe Tumor Ablation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The Europe Tumor Ablation Market has been segmented as below:

By Technology Analysis:

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technology

By Treatment Analysis:

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

By Application Analysis:

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Other Applications

By Regional Analysis:

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Turkey
  • Belgium
  • Nether lands
  • Switzerland
  • Rest of Europe

You Can Buy Full Report @: https://www.marketresearchengine.com/europe-tumor-ablation-market

 

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Tumor Ablation Market, By Technology

8 Tumor Ablation Market, By Mode of Treatment

9 Tumor Ablation Market, By Application

10 Tumor Ablation Market, By Region

11 Competitive Landscape

12 Compny Profiles

12.1 Introduction

12.2 Medtronic, PLC

12.3 Angiodynamics, Inc.

12.4 Healthtronics, Inc

12.5 Galil Medical, Inc

12.6 Boston Scientific Corporation

12.7 Neuwave Medical, Inc.

12.8 Edap Tms S.A.

12.9 Mermaid Medical A/S

12.10 Sonacare Medical, LLC

12.11 Misonix, Inc.

 

 

Media Contact

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com

 

 

Source: http://heraldkeeper.com/tumor-ablation-market-determined-cross-us-149-00-billion-europe-2024

Leave a Reply

Your email address will not be published. Required fields are marked *